This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Bismuth encephalopathy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Bismuth encephalopathy has been most commonly reported in patients taking high-dose bismuth preparations for gastrointestinal disease. Encephalopathy has also been found to follow the use of bismuth iodoform paraffin paste (BIPP), a preparation used for chronic packing of wound cavities after surgery to the head and neck (1).

Usual symptoms:

  • confusion
  • ataxia
  • myoclonus

Bismuth is thought to interfere with oxidative metabolism in the brain by binding the thiol groups of essential enzymes, and by reducing cerebral blood flow.

Encephalopathy has not been associated with the low dose bismuth preparations currently used to treat Helicobacter pylori infections.

Reference:

  • Wilson, A.P.R. (1994) The dangers of BIPP. The Lancet 344: 1313-1314

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.